Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/24/19
End: 08/30/22
Due: 08/30/23
Phase: N/A
Priority: Normal
Start: 03/28/17
End: 06/30/23
Due: 06/30/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas | NCT03783936 | Ashwin Somasundaram | user2@example.com | None | 2019-01-24 | 2022-08-30 | 2023-08-30 | - | - | 2025-07-14 |
| Pembrolizumab Plus Y90 Radioembolization in HCC Subjects | NCT03099564 | Ashwin Somasundaram | user2@example.com | None | 2017-03-28 | 2023-06-30 | 2024-06-30 | - | - | 2025-07-14 |